These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20337505)

  • 1. Hyperammoneic encephalopathy, valproic acid, and benzodiazepine withdrawal: a case series.
    Starer J; Chang G
    Am J Drug Alcohol Abuse; 2010 Mar; 36(2):98-101. PubMed ID: 20337505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate-induced hyperammonemic encephalopathy followed by benzodiazepine withdrawal in a patient with schizoaffective disorder: a differential diagnosis.
    Sarlon J; Hess E; Krasnianski A
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):E69-70. PubMed ID: 24026753
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolic encephalopathy can be a potentially life-threatening complication from valproic acid].
    Meinardi MC; van den Berg GB; Groenhuijzen A; Driessen JT; Maas HA; Wolfhagen FH
    Ned Tijdschr Geneeskd; 2008 Feb; 152(5):278-82. PubMed ID: 18333544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].
    Jiménez-Parrilla F; Pérez-Sánchez A; Núñez-Solís JM; Madruga-Garrido M; Losada-Martínez A
    Rev Neurol; 2009 Jun 1-15; 48(11):613-4. PubMed ID: 19472163
    [No Abstract]   [Full Text] [Related]  

  • 5. The problems of long-term treatment with benzodiazepines and related substances.
    Janhsen K; Roser P; Hoffmann K
    Dtsch Arztebl Int; 2015 Jan; 112(1-2):1-7. PubMed ID: 25613443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of a Single Dose of Phenobarbital for Inpatient Management of Benzodiazepine Withdrawal: A Case Report.
    Messinger JC; Hakimi E; Vercollone L
    J Addict Med; 2023 Mar-Apr 01; 17(2):230-232. PubMed ID: 36094077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal nonconvulsive seizures during detoxification for benzodiazepine abuse.
    Albiero A; Brigo F; Faccini M; Casari R; Quaglio G; Storti M; Fiaschi A; Bongiovanni LG; Lugoboni F
    Epilepsy Behav; 2012 Feb; 23(2):168-70. PubMed ID: 22200495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxcarbazepine in rapid benzodiazepine detoxification.
    Croissant B; Grosshans M; Diehl A; Mann K
    Am J Drug Alcohol Abuse; 2008; 34(5):534-40. PubMed ID: 18821451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium valproate in benzodiazepine withdrawal.
    Apelt S; Emrich HM
    Am J Psychiatry; 1990 Jul; 147(7):950-1. PubMed ID: 2113360
    [No Abstract]   [Full Text] [Related]  

  • 10. Review: Adjunctive pharmacologic approaches for benzodiazepine tapers.
    Welsh JW; Tretyak V; McHugh RK; Weiss RD; Bogunovic O
    Drug Alcohol Depend; 2018 Aug; 189():96-107. PubMed ID: 29906718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical alertness to valproic acid-induced hyperammonemia--two case reports.
    Shan JC; Hsieh MH; Liu CC; Wen CC; Liu CM
    J Psychopharmacol; 2010 Jun; 24(6):943-5. PubMed ID: 19304858
    [No Abstract]   [Full Text] [Related]  

  • 12. [Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy].
    Rottach KG; Weiss-Brummer J; Wieland U; Schmauss M
    Nervenarzt; 2000 May; 71(5):401-3. PubMed ID: 10846716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate encephalopathy and hyperammonaemia.
    O'Neill M; Dubrey RW; Grocott-Mason RM
    Postgrad Med J; 2002 May; 78(919):316-7. PubMed ID: 12151592
    [No Abstract]   [Full Text] [Related]  

  • 14. Valproate-induced hyperammonemic encephalopathy.
    Bhatia H; Raman PG
    J Assoc Physicians India; 2005 Feb; 53():158. PubMed ID: 15847043
    [No Abstract]   [Full Text] [Related]  

  • 15. Valproicacid-induced hyperammonemic encephalopathy in the emergency department.
    Pliego Cosano R; Moreno Rosauro JM; Clavero Olmos M
    Emergencias; 2019 Oct; 31(5):364-365. PubMed ID: 31625314
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and effectiveness of a fixed-dose phenobarbital protocol for inpatient benzodiazepine detoxification.
    Kawasaki SS; Jacapraro JS; Rastegar DA
    J Subst Abuse Treat; 2012 Oct; 43(3):331-4. PubMed ID: 22285834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low risk of seizures with slow flumazenil infusion and routine anticonvulsant prophylaxis for high-dose benzodiazepine dependence.
    Tamburin S; Faccini M; Casari R; Federico A; Morbioli L; Franchini E; Bongiovanni LG; Lugoboni F
    J Psychopharmacol; 2017 Oct; 31(10):1369-1373. PubMed ID: 28613124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal involvement in valproate-induced acute hyperammonemic encephalopathy.
    Soares-Fernandes JP; Machado A; Ribeiro M; Ferreira C; Figueiredo J; Rocha JF
    Arch Neurol; 2006 Aug; 63(8):1202-3. PubMed ID: 16908754
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of anticonvulsants in benzodiazepine withdrawal.
    Pages KP; Ries RK
    Am J Addict; 1998; 7(3):198-204. PubMed ID: 9702287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid-induced hyperammonemia: a case report.
    McCall M; Bourgeois JA
    J Clin Psychopharmacol; 2004 Oct; 24(5):521-6. PubMed ID: 15349008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.